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Although measles had virtually disappeared in France after
vaccination was instituted, it reappeared in 2008, with 604
cases being reported in November at the French Institute for
Public Health Surveillance (InVS). The epidemic then spread in
2009 and 2010, with 1482 and 3531 cases, respectively, being
reported [1]. Twenty-one of the 22 French regions are now
affected by the epidemic. As compared with historical epidem-
ics, this time we have seen a higher frequency in in infants
(9%) and in individuals aged 20 years or older (38%). As stated
in a recent review by Perry and Halsey [2], measles can be a
serious disease in these age groups, with more frequent com-
plications such as pneumonia or encephalitis, which certainly
explains the 30.2% and 47.5% of cases of measles in young chil-
dren and adults requiring hospitalization in 2010 [1].
The virus of the epidemic belongs to genotype D4. The D4
virus ﬁrst appeared in France in March 2008, in a small epi-
demic in the region of Reims. This strain was identical to the
subtype IMVs/Enﬁeld.GBR/14.07/(D4)) identiﬁed in England in
2007. In the last trimester of 2008, a variant strain was identi-
ﬁed in another small epidemic in Vendee (MVs/Montaigu.FRA/
43.08 (D4)) [3]. Its nucleotide sequence in the N gene differs
by 2.7% from the prototype strain of genotype D4:
Montreal.CAN/89xD4. This virus then supplanted all other
genotypes, representing 75% and 94.9% of viruses identiﬁed in
2009 and 2010. Other rare viruses were observed in 2010:
one post-vaccination strain (genotype A) and four strains of
African origin (genotype B3), Indonesian origin (genotype D8),
Indian origin (genotype D9) and Asian origin (genotype H1).
The majority of measles cases occurred in unvaccinated
individuals (82%) who had received one dose of ROR (13%)
[1], these being children or adults frequently belonging to
social groups with difﬁculty in accessing healthcare, educational
religious communities, or migrant populations. These groups
of highly receptive individuals, who were quite often mobile,
occupied an important place in the initiation of the epidemic.
But why did this genotype D4 virus emerge in the general
population?
It is certain that immunization coverage has fallen below
the recommended 95% (for ﬁrst dose at a sub-national level).
Did a variant of the measles virus emerge under any pres-
sure of selection? We know, for example, that the sera of
convalescent measles patients or of those who have been
vaccinated variably neutralize the wild virus strains [4] but,
conversely, the neutralizing capacity of the polyclonal
response of B-cells, whether induced by infection or by vac-
cination, is not affected or inﬂuenced by the genotype [5].
So did this strain have an increased virulence, giving it a
selective advantage, e.g. through its ability to infect certain
cell types, its ability to escape the antiviral defence mediated
by interferon, and increased polymerase activity?
To conclude, measles became a re-emerging disease in
France in 2008. However, its eradication is still possible if,
ﬁrst, physicians ensure proper implementation of the immu-
nization schedule and take measures to prevent transmission
of infection around index cases, and second, health authori-
ties strengthen the resources allocated to monitoring the
epidemic and viruses.
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